Background. Healthcare workers (HCWs) undergo occupational tuberculosis screening at regular intervals. However, the risk of contracting tuberculosis at the workplace in a setting with a low background tuberculosis incidence is unclear. We aimed to evaluate the risk of tuberculin skin test (TST) conversion and the risk of occupational tuberculosis infection among HCWs in such a setting.
Tuberculosis is a potential occupational hazard for healthcare workers (HCWs) worldwide. In the late 1980s in the United States, dramatic nosocomial outbreaks of multidrug-resistant tuberculosis, mainly in human immunodeficiency virus hospital wards and clinics, with transmission to HCWs were observed [1] . As a consequence, substantial investments in administrative, personal, and engineering infection control measures in many hospitals in high-income countries were made. Implementation of these measures led to successful reduction in transmission [2] [3] [4] [5] [6] , but HCWs remain at an increased risk of tuberculosis exposure compared to the general population [7] .
A systematic review published in 2007 found that rates of active tuberculosis in HCWs were higher than in the general population, not only in low-and middle-income countries, but also in high-income countries (based on studies published in 1990 and later), although findings were variable [8] . Among HCWs from low-and middle-income countries, latent tuberculosis infection (LTBI) was consistently associated with markers of occupational exposure, but in high-income countries it was more often associated with nonoccupational factors. Administrative infection control measures seemed the most effective in high-income countries.
In most countries with a low incidence of tuberculosis, HCWs routinely undergo screening for LTBI with a tuberculin skin test (TST) and/or an interferon-γ release assay (IGRA) at the time of starting employment (baseline testing) and at regular intervals and/ or after potential exposure (at the workplace, during overseas travel, etc) thereafter [9] . In HCWs with a negative baseline test, it is therefore generally possible to determine whether infection occurred during employment, although it is not always possible to ascertain whether infection was related to exposure at the workplace.
Occupational health programs have a choice between newer IGRAs and the TST for HCW tuberculosis surveillance. Guidelines of the Centers for Disease Control and Prevention (CDC) indicate that IGRA or a TST may be used without preference in surveillance programs for HCWs [9] . In the United States, some healthcare systems routinely test their employees using IGRAs, while others have continued to use TST for LTBI screening among their employees. There is good evidence that both tests are acceptable but imperfect tests for LTBI [10] . IGRAs have been shown to have a relatively high rate of spontaneous conversions-not correlated with an increased exposure risk-as well as subsequent reversions (exceeding 50% in some studies) when HCWs with positive IGRA results are retested [10] [11] [12] [13] . High IGRA conversion rates of 5%-8% reported in North American HCW studies are not compatible with the low tuberculosis incidence in this setting, as also indicated by TST conversion rates <1% in many hospitals [10] .
In the current study, we aimed to (1) examine the risk of TST conversion in a large cohort of HCWs and (2) establish the risk of occupational tuberculosis infection among HCWs with a TST conversion in a very low-incidence setting in the US Midwest with the goal to contribute to the current discussion on the optimal approach toward tuberculosis surveillance among HCWs in North America and other low-incidence settings.
METHODS

Study Setting
The study was conducted at Mayo Clinic Rochester, Minnesota, a tertiary care hospital located in an area with a very low tuberculosis incidence of only 2.7/100 000 per year in 2014 [14] . In this setting, the majority of cases of tuberculosis (82%) occur in overseas-born individuals, in particular migrants from Somalia and Ethiopia (28% and 13% of all tuberculosis cases in non-USborn individuals, respectively) [14] . The Mayo Clinic/Olmsted County TB Clinic was established in April 2001 and has since treated around 50 patients with pulmonary and/or extrapulmonary tuberculosis.
All Mayo Clinic HCWs routinely undergo baseline TST screening when they commence their employment and at predefined intervals based on institutional risk assessment (depending on the job risk category for tuberculosis exposure, varying between 6 months for high-risk jobs and 12 months for the remainder of jobs) thereafter. TST reactions are read by qualified staff 48-72 hours after injection of 0.1 mL (5 tuberculin units) of purified protein derivative into the anterior surface of the forearm.
A 2-step TST is performed at baseline if the initial TST is negative. The aim of a 2-step TST is to avoid false-negative baseline TSTs, so that a subsequent positive TST is not misinterpreted as a TST conversion. If tuberculosis infection occurred in the distant past, the immunological response to Mycobacterium tuberculosis might have waned, but the initial TST may boost the immunological memory, so that a second TST, performed within 1-3 weeks of the first test, will be positive (booster phenomenon). If employees are found to have a TST conversion, they receive a chest radiograph to exclude active tuberculosis, a QuantiFERON-TB test (QFT) for confirmation (introduced at Mayo Clinic in 2005), and a medical assessment by a physician. At the medical appointment, a detailed history is taken to evaluate possible occupational exposure to tuberculosis or exposure in the community. The option of LTBI treatment is discussed and treatment commenced, if the employee wishes to take prophylaxis. Figure 1 gives an overview of the screening process for LTBI in HCWs at Mayo Clinic.
A workplace investigation is conducted in the employees' workplace environment to determine if there are other cases with TST conversion and/or active tuberculosis.
Study Design and Population
We conducted a retrospective cohort study of all Mayo Clinic employees in Rochester, Minnesota, who had undergone TST screening during the study period 1 January 1998 to 31 May 2014. Mayo HCWs who had a TST conversion during the study period (either detected during TST routine surveillance or because of workplace contact investigation) were identified from clinical records. Detailed information was extracted from the employees' occupational medical files and included information on gender, job description (risk category for tuberculosis exposure), history of chronic disease, smoking status, history of BCG vaccination, duration of employment before TST conversion (in employees with negative baseline test and conversion during employment), TST induration size, results of initial 2-step TST, QFT results, history of tuberculosis exposure, results of workplace investigations triggered by TST conversions, history of travel, country of birth, age at immigration, reporting of LTBI after diagnosis, acceptance of LTBI treatment, and adherence to LTBI treatment.
Data Analysis and Definitions
TST conversion was defined as a positive TST of ≥10 mm and an increase of at least 6 mm in induration compared with the last TST [15] .
Reason for conversion was categorized into 3 categories: (1) occupational known exposure (part of an occupational contact tracing investigation or close occupational contact with a known tuberculosis case; (2) nonoccupational exposure (community risk factor for tuberculosis exposure identified, eg, travel to setting with high tuberculosis incidence); and (3) possible occupational exposure (no community risk factors identified).
Ethical Considerations
The study was approved by the Mayo Clinic Institutional Review Board (number 15-007662).
RESULTS
Characteristics of the Study Population
During the study period of 16 years and 5 months, 40 142 employees underwent 197 932 TST procedures for screening for LTBI. Of all tested employees, 6423 (16%) had an initial 2-step TST. Only 862 (2.1%) of all baseline TSTs were positive (≥10 mm), including 191 positive 2-step TSTs. Of 39 280 employees who had a negative TST at baseline, 123 (0.31%) had a TST conversion during the study period. If we would have applied the CDC criteria for TST conversion (change from negative to positive with an increase of ≥10 mm in induration within 2 years) [16] , 107 patients would have been classified as TST converters (4 patients with a subsequent TST ≥10 mm had a change in induration of 6-9 mm only and 13 had a TST conversion later than 2 years after the last TST was performed).
The mean age of HCWs with TST conversion was 34.5 (standard deviation, 10.2) years, 53% were male, and 64% were foreign born. Characteristics of TST converters are outlined in Table 1 . The majority (78%) of HCWs with TST conversions were aged <40 years. Foreign birth was more prevalent among younger TST converters (Table 2 ). In the age group 30-39 years, 75% of TST converters were foreign born, suggesting that foreign birth is likely the major reason why the majority of TST conversions occurred in younger HCWs.
Of 123 employees with TST conversion, 91 had a QFT done at the time of TST conversion, of which 60 (66%) showed a discordant (negative) result. Of these 66 patients, 29 patients had a history of BCG vaccination. In TST converters, the median number of TSTs performed before TST conversion was 2 (interquartile range [IQR], 1), the median time interval between the last negative TST and TST conversion was 12 (IQR, 11) months, and the median time interval between initial TST at hire and TST conversion was 32 (IQR, 16) months. The majority of TST examinations (109 [89%]) classified as conversion were conducted as routine examinations, 11 (9%) because of possible exposure to active tuberculosis at the workplace or in the community and 3 (2%) because employees had symptoms consistent with tuberculosis. None of the employees with TST conversion were diagnosed with active tuberculosis.
Occupational Versus Community Exposure to Tuberculosis in TST Converters
Of the 123 HCWs with TST conversion, only 9 (7%) had identifiable risk factors for occupational tuberculosis exposure; 40 (33%) had identifiable risk factors for tuberculosis exposure in the community (eg, travel to endemic country, contact to somebody with active tuberculosis). The majority (72 [59%]) had no identifiable risk for tuberculosis exposure at work or in the community, and 2 HCWs had no information available on exposure risk. Thirty-seven (30%) HCWs with TST conversion had traveled overseas, and 4 (3%) had high-risk jobs.
More than 61% (75/123) of TST conversions occurred in the final 3.5 years of the study between 2011 and May 2014; however, the number of TST conversations for which an occupational risk could be identified decreased in more recent years, while the number of TST conversions with identified nonoccupational exposure risk rose (Table 3) .
None of the HCWs undergoing TST screening including the 123 TST converters developed active tuberculosis during the study period. Fifty-four patients commenced LTBI treatment, 64 chose not to take treatment for LTBI, and for 5 it was not reported whether they commenced LTBI treatment. Of the 54 patients who commenced treatment, 39 (72%) completed treatment and 5 did not complete treatment; for 10 patients, it was not recorded whether they completed treatment.
DISCUSSION
In a large cohort of 40 142 HCWs, 123 (0.3%) had a TST conversion during the study observation period of 16.4 years, of which only 9 (7%) had suspected tuberculosis exposure at the workplace, indicating that the risk of occupational tuberculosis infection is very small in a low-incidence setting for tuberculosis in the US Midwest. The proportion of discordant TST/QFT results was high among TST converters who had a QFT done at the time of TST conversion (60/91 [66%]), and TST conversions might therefore frequently represent false-positive results in this context.
The rationale for routine follow-up testing for LTBI in HCWs is early identification and mitigation of occupational transmission of M. tuberculosis. CDC guidelines require surveillance testing based on a risk assessment of the healthcare setting [16] . A 2-step TST in HCWs prior to hire is intended to avoid falsely attributing a positive test early in surveillance as due to an occupational exposure rather than tuberculosis exposure prior to hire. Possible boosting during surveillance remains a problem even when a 2-step test TST was performed at onboarding. TST conversions among HCWs within 2 years of 2-step testing have been associated with foreign birth and BCG vaccination history [17] and are thus not a reliable indicator of recent tuberculosis exposure in this population. Interestingly, one study of HCWs found that TST conversions likely attributable to boosting occurred on the third or fourth TST rather than the second test [18] . In our study, TST conversions occurred most frequently on the third test as well.
In our study, a negative IGRA following TST conversion was common (66% of cases), giving some indication about the possible false-positive rate of TST conversions. There is some evidence that the TST can boost subsequent IGRA results after the first few days (day 3 post-TST), and the effect potentially wanes after 3 months [19] . Conducting an IGRA within 2 days of a suspected false-positive TST conversion is likely to avoid this boosting effect and will help to inform the discussion about potential risks and benefits of LTBI treatment in this situation.
Many HCW tuberculosis surveillance programs in low-incidence settings for tuberculosis use IGRAs instead of TSTs for regular surveillance. IGRAs are designed to have a higher specificity than the TST because of the lack of cross-reactivity with BCG [20, 21] . However, studies that assessed serial testing with IGRAs in low-risk individuals, especially HCWs in low-incidence settings, found higher false conversion rates with IGRAs than with TST [11, [22] [23] [24] . The findings from our study, that serial TST screening yielded only a small number of TST conversions and no cases of active tuberculosis developed in any of the HCWs during the study period, provide support for the use of TST for serial screening among HCWs in a very low-incidence setting.
We found a very low risk of 7% (9/123) that TST conversions were related to occupational tuberculosis exposure in our study, which is consistent with other studies that found low conversion rates among HCWs and association of TST conversion mainly with nonoccupational tuberculosis exposure [25, 26] . This finding was also confirmed in a systematic review on the risk of tuberculosis infection and disease associated with work in healthcare settings, which found that LTBI was more often associated with nonoccupational than occupational factors in high-income countries [8] .
The reasons for the substantial increase in TST conversions around 2011-2012 in our study are not entirely clear. Possible reasons are (1) increase in compliance of HCWs with mandatory tuberculosis screening (increasing from 80% in 2005 to almost 100% in 2014); (2) increase of the number of HCWs on tuberculosis surveillance (more than double the number in 2010 than 2005); and (3) an increasing proportion of HCWs born in countries with a high tuberculosis incidence in whom TST conversion is often the result of late boosting of an old tuberculosis infection or the result of more recent, but nonoccupational, exposure to active tuberculosis (eg, when traveling to the country of origin). Importantly, the number of TST conversations for which an occupational risk could be identified decreased in more recent years.
If the reason for TST testing is contact to a person with infectious tuberculosis, any TST conversion should be considered to be the result of recent transmission. If the risk that transmission could have occurred is low (taking into account the infectiousness of the person with active tuberculosis, and the duration and proximity of contact) and the HCW does not have any risk factors for tuberculosis reactivation (such as an immunosuppressive condition), a confirmatory IGRA test can be used to inform the discussion about LTBI treatment with the HCW.
A strength of our study is the very large cohort of HCWs who underwent TST screening over a study period of 16.4 years, probably the largest cohort of HCWs ever studied in the United States. Study limitations were mainly related to missing information; in particular, the results of a 2-step TST at baseline were only available for 50% of all 123 TST converters, increasing the chance of an initial false-negative result. In this case, however, the number of TST converters would have been even lower than currently estimated, further strengthening the conclusion that the risk of TST conversion in this setting is very low.
As voiced by others previously, the study results indicate a need to rethink the current approach of large-scale screening of HCWs in low-incidence settings such as the United States where the risk of tuberculosis exposure (both occupational and in the community) is very low [27] . Rather than discussing which test (TST or IGRA) should be used, we should reconsider whether it is truly worthwhile and justifiable to subject millions of HCWs in the United States and other low-incidence settings to annual tuberculosis screening [28] . While the risk of tuberculosis appears to be slightly elevated in HCWs compared to the general population [7] , infection control measures have been proven to be highly effective in decreasing nosocomial tuberculosis transmission [8, 16] . Not a single HCW who was on TST surveillance in our study developed tuberculosis during the observation period, a finding that is consistent with previous study findings in the United States, including the finding from a large prospective multicenter study among >2400 HCWs in 4 US institutions [11] . Retesting only HCWs with known exposure to tuberculosis (or a high risk of exposure, eg, during extended travel in tuberculosis-endemic areas), as already practiced in some low-incidence settings, such as Australia, could remove the problem of having to interpret positive TST/IGRA test results in HCWs with a very low pretest probability of having been infected with tuberculosis. This is also in line with current CDC recommendations, which outline that in low-risk HCWs, TST/ IGRA should only be performed at baseline and if tuberculosis exposure occurs thereafter [29] . Implementation of this approach would reduce unnecessary anxiety among low-risk HCWs with positive test results, reduce potential unwarranted treatment of LTBI with its associated risk of drug-induced hepatitis and other side effects, and allow reallocation of resources to more cost-effective tuberculosis control measures.
In conclusion, based on the results of our study in a setting with a low tuberculosis incidence and a very low risk of nosocomial tuberculosis transmission, the TST seems to be an appropriate test with only a small proportion of conversions (a majority of which might not indicate true tuberculosis infection). In this setting, only testing low-risk HCWs at baseline and when tuberculosis exposure occurs, rather than at regular intervals, should be considered.
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